Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.31 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.30 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.30 |
| ▸ | ITGAL | P20701 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3026078 | 1.00 | KDM4E (0.34) | KDM4EALDH1A1HSD17B10PKMHPGD | |
| SCHEMBL3017928 | 0.91 | LMNA (0.33) | KDM4EALDH1A1HSD17B10LMNAITGB2 | |
| SCHEMBL3017925 | 0.91 | LMNA (0.33) | KDM4EALDH1A1HSD17B10LMNAITGB2 | |
| SCHEMBL3015521 | 0.91 | KDM4E (0.32) | KDM4EALDH1A1HSD17B10PKMHPGD | |
| SCHEMBL3021667 | 0.89 | LMNA (0.35) | KDM4EALDH1A1PKMHPGDLMNA | |
| SCHEMBL3021665 | 0.89 | LMNA (0.35) | KDM4EALDH1A1PKMHPGDLMNA | |
| SCHEMBL3799237 | 0.89 | LMNA (0.35) | LMNA | |
| SCHEMBL3799235 | 0.89 | LMNA (0.35) | LMNA | |
| SCHEMBL3024912 | 0.88 | KDM4E (0.33) | KDM4EALDH1A1HSD17B10PKMHPGD | |
| SCHEMBL3024910 | 0.88 | KDM4E (0.33) | KDM4EALDH1A1HSD17B10PKMHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100190794-A1 | Herbicidally Active Composition | BASF SE (DE) | 2010-07-29 | — | — | US | claimed |
| US-20100152047-A1 | Piperazine Compounds Whith a Herbicidal Action | BASF SE (DE) | 2010-06-17 | — | — | US | claimed |
| US-20100190794-A1 | Herbicidally Active Composition | BASF SE (DE) | 2010-07-29 | — | — | US | disclosed |
| US-20100152047-A1 | Piperazine Compounds Whith a Herbicidal Action | BASF SE (DE) | 2010-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152047-A1 | Piperazine Compounds Whith a Herbicidal Action | CBR3, CBR1, CNPY2 | KDM4E 4015/4885ALDH1A1 983/4885HSD17B10 790/4885 |
| US-20100190794-A1 | Herbicidally Active Composition | ECI1, ACLY, SQOR | KDM4E 2283/4885ALDH1A1 1128/4885HSD17B10 121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.